G. Riebandt

Bevacizumab for the treatment of recurrent ovarian cancer: a retrospective cohort study.

K. Odunsi, S. Lele, S. Akers, 2013, European journal of gynaecological oncology.

Oxaliplatin Is a Safe Alternative Option for Patients With Recurrent Gynecologic Cancers After Hypersensitivity Reaction to Carboplatin

K. Odunsi, Austin Miller, S. Lele, 2015, International Journal of Gynecologic Cancer.

856 Preliminary review of Diabetes Mellitus incidence in patients treated with immune checkpoint inhibitors (ICI) therapy – Roswell Park Comprehensive Cancer Center (RPCCC) experience

Rajeev Sharma, G. Riebandt, Zhen Zhang, 2020, Journal for ImmunoTherapy of Cancer.

Postoperative Restrictive Opioid Protocols and Durable Changes in Opioid Prescribing and Chronic Opioid Use.

A. Fabiano, K. Odunsi, W. Hicks, 2023, JAMA oncology.

Oncology pharmacy practice in the United States: Results of a comprehensive, nationwide survey

Stephen Harnicar, G. Riebandt, Shannon M Hough, 2023, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Incidence of Diabetes Mellitus in patients treated with immune checkpoint inhibitors (ICI) therapy - A Comprehensive Cancer Center experience.

Rajeev Sharma, K. Attwood, G. Riebandt, 2023, Diabetes research and clinical practice.